RBC
NUS icon

Ronald Blue & Co’s Nu Skin NUS Stock Holding History

Ronald Blue & Co’s Portfolio NUS Stock Details NUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$207K Buy
+3,298
New +$188K 0.01% 210

Other funds holding NUS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
AL
AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
PGP
Prescott General Partners Boca Raton, Florida $1.37B AUM 23.81% 1-Year Est. Return

Ronald Blue & Co's NUS Position: Q2 2017 in Review

Ronald Blue & Co opened a new position in Nu Skin (NUS) in Q2 2017: 3,298 shares worth $207K. The stake represents 0.01% of the portfolio and ranks #210 among its holdings.

266 funds tracked by Wall St. Rank hold NUS as of Q2 2017.

  • Ronald Blue & Co held 3,298 shares of Nu Skin worth $207K as of Q2 2017.
  • Nu Skin was a new Ronald Blue & Co position in Q2 2017.
  • Nu Skin made up 0.01% of Ronald Blue & Co's portfolio in Q2 2017, its #210 holding.
  • 266 funds tracked by Wall St. Rank held Nu Skin as of Q2 2017.

Based on Ronald Blue & Co's 13F filing for Q2 2017, filed 28 Jul 2017.